Astria Therapeutics (ATXS) Q2 2025 Earnings

13MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.58
-0.51
-0.44
-0.37

Details

Expected EPS
-0.478333
Actual EPS
-0.58
Surprise EPS
-0.1
Surprise Percent
+21.25%

Description

Astria Therapeutics (ATXS) has reported earnings of -0.58 per share for Q2 2025.

0 Comments

Share your thoughts